相关实验视频
Updated: May 12, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
使用生物信息学工具在三阴性乳腺癌细胞中识别与化的抗癌活性相关的基因
Eduardo De la Cruz-Cano1, José Ángel González-Díaz1, Ivonne María Olivares-Corichi2
1Laboratorio de Bioquímica y Biología Molecular, División Académica de Ciencias Básicas, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán C.P. 86690, Mexico.
新型化石块在三阴性乳腺癌 (TNBC) 治疗方面表现有前途. 这项研究确定了关键的基因和通路,包括HSF1调节和压力诱导的亡,为TNBC提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
- 在瘤学瘤学.
背景情况:
- 化石刻具有针对三阴性乳腺癌 (TNBC) 的抗癌特性.
- 它们的有效性背后的精确分子机制仍未得到充分探索.
研究的目的:
- 研究一种新型化石 (化合物3) 对TNBC细胞的分子机制.
- 为了确定差异表达的基因和相关的生物途径受到化合物3治疗的影响.
主要方法:
- 通过克莱森-施密特反应合成一种新的化石.
- 使用Illumina NextSeq500进行MDA-MB-231细胞的转录组分析.
- 使用DESeq2.2.5进行差异表达基因的生物信息识别 (gadgadlog2FCgadgad ≥2,调整后p <0.05).
主要成果:
- 鉴定了504个在对化合物3的反应中差异表达的基因.
- 丰富分析显示,它与"细胞死亡调节"和"对未折叠蛋白质的反应"有关.
- 发现了"依赖HSF1的交换活化通路"和"减弱阶段通路"的参与.
结论:
- 化可能会调节HSF1沉声器.
- 化合物3对参与压力诱导的亡的基因进行上调.
- 这种化合物有可能成为TNBC的新型治疗剂.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...